Gufic Biosciences Limited (NSE:GUFICBIO)
370.65
-2.15 (-0.58%)
Jun 13, 2025, 3:29 PM IST
Gufic Biosciences Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 13, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Market Capitalization | 37,293 | 33,738 | 28,394 | 18,095 | 24,129 | 8,896 | Upgrade
|
Market Cap Growth | 18.82% | 18.82% | 56.92% | -25.01% | 171.24% | 142.42% | Upgrade
|
Enterprise Value | 40,365 | 36,504 | 31,818 | 19,487 | 23,753 | 10,059 | Upgrade
|
Last Close Price | 370.65 | 336.30 | 282.43 | 186.29 | 248.73 | 114.32 | Upgrade
|
PE Ratio | 53.54 | 48.44 | 32.96 | 22.70 | 25.18 | 20.11 | Upgrade
|
PS Ratio | 4.55 | 4.12 | 3.52 | 2.62 | 3.10 | 1.82 | Upgrade
|
PB Ratio | 6.20 | 5.61 | 5.33 | 5.20 | 8.97 | 5.13 | Upgrade
|
P/TBV Ratio | 6.27 | 5.67 | 5.39 | 5.21 | 8.99 | 5.14 | Upgrade
|
P/FCF Ratio | 79.28 | 71.72 | - | - | 128.44 | 11.89 | Upgrade
|
P/OCF Ratio | 30.43 | 27.53 | - | - | 22.71 | 10.20 | Upgrade
|
EV/Sales Ratio | 4.92 | 4.45 | 3.94 | 2.82 | 3.05 | 2.06 | Upgrade
|
EV/EBITDA Ratio | 29.97 | 27.10 | 22.60 | 14.91 | 16.61 | 12.51 | Upgrade
|
EV/EBIT Ratio | 35.52 | 32.13 | 24.26 | 16.90 | 18.40 | 14.87 | Upgrade
|
EV/FCF Ratio | 85.81 | 77.60 | - | - | 126.44 | 13.44 | Upgrade
|
Debt / Equity Ratio | 0.56 | 0.56 | 0.63 | 0.96 | 0.24 | 0.36 | Upgrade
|
Debt / EBITDA Ratio | 2.50 | 2.50 | 2.25 | 2.43 | 0.44 | 0.73 | Upgrade
|
Debt / FCF Ratio | 7.15 | 7.15 | - | - | 3.43 | 0.82 | Upgrade
|
Asset Turnover | 0.73 | 0.73 | 0.83 | 1.00 | 1.71 | 1.22 | Upgrade
|
Inventory Turnover | 1.80 | 1.80 | 2.08 | 2.27 | 4.01 | 2.37 | Upgrade
|
Quick Ratio | 0.89 | 0.89 | 0.89 | 0.81 | 0.88 | 0.80 | Upgrade
|
Current Ratio | 1.61 | 1.61 | 1.61 | 1.61 | 1.72 | 1.59 | Upgrade
|
Return on Equity (ROE) | 12.29% | 12.29% | 19.57% | 25.84% | 43.31% | 29.22% | Upgrade
|
Return on Assets (ROA) | 6.28% | 6.28% | 8.39% | 10.43% | 17.67% | 10.58% | Upgrade
|
Return on Capital (ROIC) | 7.88% | 7.88% | 10.59% | 14.20% | 28.39% | 17.23% | Upgrade
|
Return on Capital Employed (ROCE) | 14.50% | 14.50% | 18.20% | 20.10% | 38.50% | 29.60% | Upgrade
|
Earnings Yield | 1.87% | 2.06% | 3.03% | 4.41% | 3.97% | 4.97% | Upgrade
|
FCF Yield | 1.26% | 1.39% | -4.23% | -11.84% | 0.78% | 8.41% | Upgrade
|
Dividend Yield | 0.03% | 0.03% | 0.03% | 0.05% | 0.04% | 0.09% | Upgrade
|
Payout Ratio | 1.44% | 1.44% | 1.13% | 1.31% | 0.96% | 0.82% | Upgrade
|
Buyback Yield / Dilution | -1.72% | -1.72% | -1.63% | - | - | -24.56% | Upgrade
|
Total Shareholder Return | -1.69% | -1.69% | -1.59% | 0.05% | 0.04% | -24.47% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.